JP2024534499A5 - - Google Patents
Info
- Publication number
- JP2024534499A5 JP2024534499A5 JP2024517427A JP2024517427A JP2024534499A5 JP 2024534499 A5 JP2024534499 A5 JP 2024534499A5 JP 2024517427 A JP2024517427 A JP 2024517427A JP 2024517427 A JP2024517427 A JP 2024517427A JP 2024534499 A5 JP2024534499 A5 JP 2024534499A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- recombinant polypeptide
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163247239P | 2021-09-22 | 2021-09-22 | |
| US63/247,239 | 2021-09-22 | ||
| PCT/US2022/076862 WO2023049803A1 (en) | 2021-09-22 | 2022-09-22 | Il5ra cell surface markers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534499A JP2024534499A (ja) | 2024-09-20 |
| JP2024534499A5 true JP2024534499A5 (cg-RX-API-DMAC7.html) | 2025-09-30 |
Family
ID=85721256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517427A Pending JP2024534499A (ja) | 2021-09-22 | 2022-09-22 | Il5ra細胞表面マーカー |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240417443A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4405383A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534499A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240069766A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118251407A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022349077A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3232203A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024003250A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023049803A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121538180A (zh) * | 2025-11-28 | 2026-02-17 | 中国医学科学院肿瘤医院 | 经修饰的单核细胞、其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453491A (en) * | 1990-09-11 | 1995-09-26 | Kiyoshi Takatsu | Murine interleukin-5 receptor |
| DE60112282T2 (de) * | 2000-05-22 | 2006-04-20 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. | Auf rezeptorgrundlage arbeitende screening-verfahren für protein wechselwirkungen |
| PT3072525T (pt) * | 2007-05-14 | 2018-04-20 | Astrazeneca Ab | Métodos para reduzir os níveis de basófilos |
| ES3053874T3 (en) * | 2015-08-24 | 2026-01-27 | Glaxosmithkline Ip No 2 Ltd | Biopharmaceutical compositions |
| HK1255922A1 (zh) * | 2015-11-04 | 2019-09-06 | Astrazeneca Ab | 二肽基肽酶-4和骨膜素作为嗜酸性粒细胞疾病中嗜酸性粒细胞靶向治疗药物临床反应的预测因子 |
| EP3635132A4 (en) * | 2017-06-07 | 2021-05-26 | Intrexon Corporation | EXPRESSION OF NOVEL CELL MARKERS |
| IL296242A (en) * | 2020-03-10 | 2022-11-01 | Massachusetts Inst Technology | Methods for generating engineered memory-like nk cells and compositions thereof |
-
2022
- 2022-09-22 WO PCT/US2022/076862 patent/WO2023049803A1/en not_active Ceased
- 2022-09-22 CN CN202280074739.XA patent/CN118251407A/zh active Pending
- 2022-09-22 EP EP22873860.5A patent/EP4405383A4/en active Pending
- 2022-09-22 AU AU2022349077A patent/AU2022349077A1/en active Pending
- 2022-09-22 KR KR1020247012657A patent/KR20240069766A/ko active Pending
- 2022-09-22 US US18/693,418 patent/US20240417443A1/en active Pending
- 2022-09-22 CA CA3232203A patent/CA3232203A1/en active Pending
- 2022-09-22 MX MX2024003250A patent/MX2024003250A/es unknown
- 2022-09-22 CN CN202411599318.6A patent/CN119661725A/zh active Pending
- 2022-09-22 JP JP2024517427A patent/JP2024534499A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110818802B (zh) | 一种嵌合t细胞受体star及其应用 | |
| JP2865300B2 (ja) | ヒトb細胞刺激因子2レセプター蛋白質 | |
| JP2021191265A5 (cg-RX-API-DMAC7.html) | ||
| JP2023071729A5 (cg-RX-API-DMAC7.html) | ||
| JP2010516758A5 (cg-RX-API-DMAC7.html) | ||
| JP2021525534A5 (cg-RX-API-DMAC7.html) | ||
| CN111892661A (zh) | 一种嵌合抗原受体及其在制备治疗肿瘤的产品中的应用 | |
| CN115698081A (zh) | 靶向bcma的嵌合抗原受体及其用途 | |
| EP4021932B1 (en) | Tcr constructs specific for ebv-derived antigens | |
| CN111875708A (zh) | 一种嵌合抗原受体t淋巴细胞及其在制备治疗实体肿瘤的产品中的应用 | |
| CN108728460A (zh) | 靶向gd2的嵌合抗原受体及其用途 | |
| TW202300522A (zh) | 編碼對抗乙醯膽鹼受體自體抗體之嵌合受體之基因 | |
| WO2020253879A1 (zh) | 一种双特异性嵌合抗原受体 | |
| JP2024502235A5 (cg-RX-API-DMAC7.html) | ||
| EP3898665B1 (en) | Cd22-specific t cell receptors and adoptive t cell therapy for treatment of b cell malignancies | |
| WO2025055790A1 (zh) | 细胞因子融合蛋白及其应用 | |
| US20240018197A1 (en) | Hook fusion protein for regulating the cellular trafficking of a target protein | |
| EP0870040A2 (en) | Gene delivery vehicle-targeting ligands | |
| US11980671B2 (en) | Use of bacterial voltage gated ion channels for human therapies | |
| CN115947824A (zh) | 突变的人源t细胞受体恒定区、t细胞受体及t细胞受体修饰的细胞及应用 | |
| JP2023540123A5 (cg-RX-API-DMAC7.html) | ||
| CN108484778B (zh) | 人源化ghr106单克隆抗体的嵌合抗原受体构建体及核酸分子与应用 | |
| JP6018079B2 (ja) | 非天然micタンパク質 | |
| JP2024516610A5 (cg-RX-API-DMAC7.html) | ||
| CA2660178C (en) | Promiscuous her-2/neu cd4 t cell epitopes |